What should you know about Letara letrozole 2.5 mg?

Letrozole blocks aromatase, an enzyme the body uses to make oestrogen after menopause. Lower oestrogen can reduce stimulation of hormone-sensitive breast cancer cells. Letara is a brand of letrozole; the prescribed strength and schedule should be followed exactly. It is not a general cancer medicine and is not suitable for every breast cancer or every person.

Common treatment concerns include hot flushes, joint or muscle aches, tiredness, headache and changes in bone strength. Symptoms vary, and your team can review whether they relate to letrozole or another cause.

Take the tablet as prescribed and tell your clinician about other medicines, supplements, liver problems, cholesterol concerns and any history of fragile bones. Do not double the next dose after forgetting one; ask your pharmacist or oncology team what to do. Aromatase inhibitor therapy may include bone health review, movement advice and checks chosen for your circumstances. Report persistent joint pain or difficulty with daily activities so the plan can be adjusted safely.

Contact your care team promptly for severe or persistent pain, a new fracture, marked weakness, unusual vaginal bleeding or symptoms that interfere with eating, walking or sleep. Seek urgent help for chest pain, sudden breathlessness, one-sided weakness, facial swelling or a severe allergic reaction. Do not stop letrozole without discussing it, unless emergency clinicians tell you to do so.

Why is letrozole suitable for my tumour? How should I take this brand and manage a missed dose? Do I need bone health checks or vitamin advice? Which side effects merit a call, and are there alternatives if joint symptoms continue?